| NCT ID | NCT07502456 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alcon Research |
| Condition | Aphakia |
| Study Type | INTERVENTIONAL |
| Enrollment | 122 participants |
| Start Date | 2026-05-26 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 122 participants in total. It began in 2026-05-26 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed. IOLs are intended to remain in the eyes for the duration of the patient's lifetime.
Eligibility Criteria
Key Inclusion Criteria: * Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification. * Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator. * Astigmatism suitable for correction with available toric IOL models. * Other protocol-specified inclusion criteria may apply. Key Exclusion Criteria: * Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol. * Moderate to severe dry eye that would affect study measurements. * Other protocol-specified exclusion criteria may apply.
Contact & Investigator
Clinical Trial Lead, Surgical
STUDY DIRECTOR
Alcon Research, LLC
Frequently Asked Questions
Who can join the NCT07502456 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Aphakia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07502456 currently recruiting?
Yes, NCT07502456 is actively recruiting participants. Contact the research team at alcon.medinfo@alcon.com for enrollment information.
Where is the NCT07502456 trial being conducted?
This trial is being conducted at Phoenix, United States, Brecksville, United States, Mt. Pleasant, United States, Sugar Land, United States and 1 additional location.
Who is sponsoring the NCT07502456 clinical trial?
NCT07502456 is sponsored by Alcon Research. The principal investigator is Clinical Trial Lead, Surgical at Alcon Research, LLC. The trial plans to enroll 122 participants.